Search

everythinglearnresearchcommunity

for

Search:↓

Research 3 of 75

1. 544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1) Journal of Investigative Dermatology · 2019 · 5 citations
2. 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata 2019
3. JAK inhibition in the treatment of alopecia areata – a promising new dawn? Expert review of clinical pharmacology · 2019 · 29 citations

Community

— no results